Industry News
Race & institutional factors play an important role in pharmacogenomic trial participation
7/28/2015
White patients and larger well-supported institutions are more likely to have higher participation rates in pharmacogenomic trialsCancer therapy has evolved from a "one-size-fits-all" type of...
Pitt study: Ancient proteins involved in DNA repair could shed light on tumor development
7/28/2015
By studying the yeast used in beer- and bread-making, researchers at the University of Pittsburgh School of Medicine have uncovered the mechanism by which ancient proteins repair DNA damage and how...
Clinical validation for LOXO-101 against TRK fusion cancer
7/28/2015
First confirmed patient response to new drugThe University of Colorado Cancer Center and Loxo Oncology, Inc.
Breast cancer survivors who experience pain during intercourse may benefit from lidocaine
7/28/2015
Dyspareunia, or painful sexual intercourse, is a common side effect of breast cancer treatment due to low estrogenScientists at Oregon Health & Science University report that breast cancer...
Gene therapy may improve survival of patients with recurrent ovarian cancer
7/28/2015
Modified version of developmental protein inhibited tumor growth in animal modelUse of gene therapy to deliver a protein that suppresses the development of female reproductive organs may improve...
Yale study identifies 'major player' in skin cancer genes
7/28/2015
A multidisciplinary team at Yale, led by Yale Cancer Center members, has defined a subgroup of genetic mutations that are present in a significant number of melanoma skin cancer cases.
Narrowing in on pituitary tumors
7/28/2015
New technique to map hormone levels in near real-time could help surgeons detect and remove tumors with precisionAs many as 20 percent of people may have a benign cyst or tumor in their pituitary...
Scientists' silk structure is secret to process of regenerating salivary cells
7/28/2015
Tissue engineering could help millions in the US with dry mouth due to Sjögren's syndrome, and radiation for head and neck cancerThe silkworm, which produces the essential ingredient for fine...
New treatment options for a fatal leukemia
7/28/2015
Acute lymphoblastic leukemia (ALL) frequently develops between the age of two and three.
In CRISPR advance, scientists successfully edit human T cells
7/28/2015
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.